SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-22-024146
Filing Date
2022-08-26
Accepted
2022-08-26 14:48:23
Documents
5
Period of Report
2022-08-26

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 717224
2 def14a_001.jpg GRAPHIC 465942
3 def14a_002.jpg GRAPHIC 340651
4 def14a_003.jpg GRAPHIC 304715
5 def14a_004.jpg GRAPHIC 243536
  Complete submission text file 0001493152-22-024146.txt   2583642
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39717 | Film No.: 221204436
SIC: 2834 Pharmaceutical Preparations